Poland· PL-100452367
Scopolamine butylbromide Kalceks
A butylscopolamine product containing hyoscini butylbromidum, registered in Poland by AS Kalceks. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Butylscopolamine is registered in 11 of 19 countries.
Countries holding a registration under ATC A03BB01 (butylscopolamine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Butylscopolamine · ATC A03BB01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Hyoscini butylbromidum
- Manufacturer
- AS Kalceks
- Country
- Poland (PL)
- ATC code
- A03BB01
- ATC class
- Butylscopolamine
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin04750341007690
- gtin04750341007706
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A03BB01
Butylscopolamine, as other registers publish it.
- CanadaACCEL-HYOSCINEACCEL PHARMA INC
- PolandAuroGastroAurovitas Pharma Polska Sp. z o.o.
- DenmarkBumacorMacure Pharma ApS
- FinlandBumacorMacure Pharma ApS
- NorwayBumacorMacure Pharma ApS
- FinlandBumofarmOrifarm Oy
- PolandBuscolysinSopharma Warszawa Sp. z o.o.
- FinlandBuscopanBoehringer Ingelheim International GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7d9006d-8bd5-401b-b450-a16b8b448b96 GET /v1/drugs/d7d9006d-8bd5-401b-b450-a16b8b448b96?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "20 mg/ml",
"packaging": "04750341007690 ¦ Rp ¦ 142286\n10 amp. 1 ml\n04750341007706 ¦ Rp ¦ 142287\n5 amp. 1 ml",
"substance": "Hyoscini butylbromidum 20 mg/ml",
"common_name": "Hyoscini butylbromidum",
"pl_product_id": "100452367",
"pozwolenie_nr": "26701",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about butylscopolamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.